PharmiWeb.com - Global Pharma News & Resources

Press Releases - 2020-05-13

Date Title Company
13-May-2020 Janssen's BCMA CAR-T Therapy JNJ-4528 Showed Early, Deep and Durable Responses in Heavily Pretreated Patients with Multiple Myeloma The Janssen Pharmaceutical Companies of Johnson & Johnson
13-May-2020 ERLEADA® (apalutamide) Significantly Improved Overall Survival in Patients with Non-Metastatic Castration-Resistant Prostate Cancer Janssen Oncology
13-May-2020 Helsinn and MEI Pharma Announce Updated Clinical Data from the Phase 2 Study Evaluating Pracinostat in Combination with Azacitidine in Patients with High/Very-high Risk Myelodysplastic Syndromes MEI Pharma, Inc.
13-May-2020 Helsinn and MEI Pharma Announce Updated Clinical Data from the Phase 2 Study Evaluating Pracinostat in Combination with Azacitidine in Patients with High/Very-high Risk Myelodysplastic Syndromes MEI Pharma, Inc.
13-May-2020 ­­­­­­­­­Marker Therapeutics to Report Updated Results from Phase 1/2 Trial with MultiTAA-Specific T Cell Therapy in Patients with Pancreatic Adenocarcinoma at ASCO 2020 Annual Meeting Marker Therapeutics, Inc.
13-May-2020 Polynoma Presenting Final Analysis of MAVIS Phase III Part B1 Data of Its Investigational Melanoma Vaccine, Seviprotimut-L, at ASCO20 Virtual Scientific Program Polynoma LLC
13-May-2020 Sanofi to showcase oncology portfolio and innovative pipeline at ASCO20 Virtual Scientific Program Sanofi
13-May-2020 Regeneron Presentations at ASCO 2020 Showcase Diverse Clinical Oncology Portfolio Regeneron Pharmaceuticals, Inc.
13-May-2020 Amgen Showcases Oncology Pipeline At ASCO 2020 Amgen
13-May-2020 Lilly Oncology Showcases Innovation in Cancer Research at ASCO 2020 Eli Lilly and Company
13-May-2020 Biocept Reports First Quarter 2020 Financial Results Biocept, Inc.
13-May-2020 Akero Therapeutics Reports First Quarter 2020 Financial Results Akero Therapeutics, Inc.
13-May-2020 Immunic, Inc. Receives First Regulatory Approval from German Health Authority BfArM to Initiate a Phase 2 Clinical Trial of its Selective Oral DHODH Inhibitor, IMU-838, in COVID-19 Patients Immunic, Inc.
13-May-2020 DTx Pharma Receives Prestigious Funding Award to Support Research in Neurodegenerative Diseases of the CNS DTx Pharma
13-May-2020 Hetero Enters Into a Licensing Agreement With Gilead Sciences, Inc. for the Manufacturing and Distribution of "Remdesivir" in 127 Countries, Including India, for COVID-19 Hetero
13-May-2020 Mylan to Present at the 2020 RBC Capital Markets' Virtual Global Healthcare Conference Mylan N.V.
13-May-2020 Micro Labs USA Inc and Saptalis Pharmaceuticals LLC Announce Launch of Metformin Oral Solution (500 mg/5mL in two presentations 118mL and 473mL) Micro Labs USA
13-May-2020 Cardiff Oncology Enters Agreement with PoC Capital to Fund Phase 2 Clinical Trial of Onvansertib in KRAS-Mutated Metastatic Colorectal Cancer (mCRC) Cardiff Oncology, Inc.
13-May-2020 ADVANZ PHARMA Corp. Limited Announces First Quarter 2020 Results ADVANZ PHARMA Corp.
13-May-2020 Microsoft Grant for CoVID-19 Research to Shoolini Univ Scientists Shoolini University